1-丁氧基-4-甲氧基丁烷 | 91391-43-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-丁氧基-4-甲氧基丁烷
• 英文名称: 1-Butoxy-4-methoxybutan
• 英文别名: 1-butoxy-4-methoxy-butane；1-Methoxy-4-butyloxy-butan；1-Butoxy-4-methoxybutane
• CAS: 91391-43-4
• 化学式: C₉H₂₀O₂
• 分子量: 160.257
• InChiKey: FBPKXEFBJHBHJN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-溴-4-甲氧基丁烷 、 正丁醇 生成 1-丁氧基-4-甲氧基丁烷
  参考文献：
  名称：

  Kirmse, Wolfgang; Jansen, Ulrich, Chemische Berichte, 1985, vol. 118, # 7, p. 2607 - 2625

  摘要：

  DOI：

文献信息

• Method for producing n-alkenyl amides
  申请人：——

  公开号：US20030028035A1

  公开（公告）日：2003-02-06

  A process for preparing N-alkenyl-amides by reacting the corresponding NH-amides with acetylenes in the liquid phase in the presence of basic alkali metal compounds and of a cocatalyst comprises using as the cocatalyst compounds of the general formulae (Ia) and/or (Ib) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n —H  (Ia): R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n —R 2 ,  (Ib): where n is 1, 2 or 3 and R 1 and R 2 are independently C 1 - to C 6 -alkyl or C 2 - to C 6 -alkenyl, or together a butenyl unit.

  制备N-烯基酰胺的过程包括通过在液相中让相应的NH-酰胺与炔烃反应，在碱性金属化合物和共催化剂的存在下，作为共催化剂使用的是具有以下通式(Ia)和/或(Ib)的化合物：R1O—(CH2CH2CH2CH2O)n—H  (Ia):R1O—(CH2CH2CH2CH2O)n—R2,  (Ib):其中n为1、2或3，R1和R2独立地为C1至C6烷基或C2至C6烯基，或者共同构成一个丁烯基团。
• Method for producing alkenyl ethers
  申请人：——

  公开号：US20030114715A1

  公开（公告）日：2003-06-19

  Alkenyl ethers are prepared by reacting the corresponding alcohols or phenols with acetylenes in the liquid phase in the presence of basic alkali metal compounds and a cocatalyst comprising compounds of the formula (Ia) and/or (Ib) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n— H  (Ia) R 1 O—(CH 2 CH 2 CH 2 CH 2 O) n— H 2 ,  (Ia) where R 1 , R 2 are, independently of one another, C 1 -C 6 -alkyl or C 2 -C 6 -alkenyl, or R 1 and R 2 together form a butyl unit and n is 1, 2, 3, 4 or 5.

  烯丙醚通过在液相中存在碱性金属化合物和协同催化剂的情况下，将相应的醇或酚与乙炔反应制备而成，其中所述协同催化剂包括化合物(Ia)和/或(Ib)的公式，(Ia)R1O—(CH2CH2CH2CH2O)n—H  (Ia)R1O—(CH2CH2CH2CH2O)n—H2,  (Ia)其中，R1，R2是独立的C1-C6烷基或C2-C6烯基，或R1和R2共同形成丁基单元，n为1、2、3、4或5。
• OLIGOMERIC COMPOUNDS COMPRISING 4'-THIONUCLEOSIDES FOR USE IN GENE MODULATION
  申请人：Bhat Balkrishen

  公开号：US20100324277A1

  公开（公告）日：2010-12-23

  The present invention provides modified oligomeric compounds and compositions of oligomeric compounds for use in the RNA interference pathway of gene modulation. The modified oligomeric compounds include siRNA and asRNA having at least one affinity modification.

  本发明提供了修改的寡核苷酸化合物和寡核苷酸化合物组合物，用于基因调节的RNA干扰途径。修改的寡核苷酸化合物包括至少具有一种亲和力修饰的siRNA和asRNA。
• Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0763524A1

  公开（公告）日：1997-03-19

  Compounds of formula (I): wherein: R1 is alkyl; R2a, R2b, R2c and R2d are the same or different and each is hydrogen, optionally substituted alkyl or various other organic groups; R3 is alkyl; R4 is a group of formula (II), (III), (IV), (V), (VI), (VII), (VIII) or (IX): wherein: A1 is a single bond, alkylene or alkenylene; A2 is or alkenylene; A3 is a single bond, alkyleneor alkenylene; R5a and R5b are the same or different and each is hydrogen, alkyl or various other groups; R6 is alkyl or phenyl; R7 is hydrogen or alkyl; R8 is alkyl or various other groups; and n is 0 or 1] and pharmaceutically acceptable salts thereof have valuable inhibitory activity against acyl-CoA: cholesterol acyl transferase.

  式(I)化合物： 其中R1 是烷基；R2a、R2b、R2c 和 R2d 相同或不同，各自是氢、任选取代的烷基或各种其它有机基团；R3 是烷基；R4 是式 (II)、(III)、(IV)、(V)、(VI)、(VII)、(VIII) 或 (IX) 的基团： 其中A1 是单键、亚烷基或烯基；A2 是或烯基；A3 是单键、亚烷基或烯基；R5a 和 R5b 相同或不同，且各自是氢、烷基或各种其它基团；R6 是烷基或苯基；R7 是氢或烷基；R8 是烷基或各种其它基团；以及 n 是 0 或 1]及其药学上可接受的盐类对酰基-CoA：胆固醇酰基转移酶具有宝贵的抑制活性。
• Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same
  申请人：MITSUI TOATSU CHEMICALS, INCORPORATED

  公开号：EP0751133A1

  公开（公告）日：1997-01-02

  The present invention relates to a novel pyrimidine compound represented by the following Formulas (1) and (2). These compounds are useful as components for liquid crystal compositions, and a liquid crystal composition containing the compound of the present invention provides a liquid crystal element having excellent characteristics such as high speed response, orientation and high contrast ratio. wherein R1 and R2 each represent a linear or branched alkyl group, alkoxyl group having 1 to 24 carbon atoms, or a linear or branched alkenyl group or alkenyloxy group having 2 to 24 carbon atoms each of which may be substituted; R3 and R4 each represent a linear or branched alkyl group or alkenyl group having 3 to 24 carbon atoms each of which may be substituted; A1 and A2 each represent a substituted or unsubstituted 1,4-phenylene group, a pyridine-2,5-diyl group or a trans-1,4-cyclohexylene group; X1 and X2 each represent a single bond, a -COO- group, a -OCO- group, a -OCH2- group or a -CH2O- group; Y1 and Y2 each represent a -COO- group or a -OCO- group; and a, b, p, q, m and n each represent 0 or 1, provided that a + b + p + q is not 0.

  本发明涉及由以下式子（1）和（2）代表的新型嘧啶化合物。这些化合物可用作液晶组合物的成分，含有本发明化合物的液晶组合物可提供具有高速响应、定向和高对比度等优异特性的液晶元件。 其中 R1 和 R2 分别代表具有 1 至 24 个碳原子的直链或支链烷基、烷氧基或具有 2 至 24 个碳原子的直链或支链烯基或烯氧基，其中每个基团都可以被取代；R3 和 R4 分别代表具有 3 至 24 个碳原子的直链或支链烷基或烯基，其中每个基团都可以被取代；A1和A2各自代表取代或未取代的1,4-亚苯基、吡啶-2,5-二基或反式-1,4-环己烯基； X1和X2各自代表单键、-COO-基团、-OCO-基团、-OCH2-基团或-CH2O-基团；Y1和Y2各自代表一个-COO-基团或一个-OCO-基团；以及a、b、p、q、m和n各自代表0或1，条件是a + b + p + q不为0。